Head-to-head comparison of the ability of the cardiometabolic index and triglyceride-glucose index to predict 3-year major adverse cardiovascular events in patients with atrial fibrillation: insights from a community cohort

Lipids Health Dis. 2026 Jan 20. doi: 10.1186/s12944-025-02848-4. Online ahead of print.ABSTRACTBACKGROUND: Atrial fibrillation (AF) represents the most common sustained cardiac arrhythmia and confers an elevated risk of major adverse cardiovascular events (MACEs). Emerging evidence indicates that me

X Xunhan Qiu

Global drivers of heart failure attributable to atrial fibrillation/flutter: insights from Joinpoint regression, age-period-cohort analysis, and future projections from the GBD 2021 Study

BMC Med. 2026 Jan 20. doi: 10.1186/s12916-026-04628-y. Online ahead of print.ABSTRACTBACKGROUND: Heart failure attributable to atrial fibrillation/flutter (HF-AF/AFL) represents a growing global public health challenge. However, comprehensive analyses of its long-term trends, the independent effects

J Jing Chen

Association between the triglyceride glucose index:Chinese visceral adiposity index (TyG-CVAI) and new-onset cardiovascular disease in middle-aged and older adults-insights from the China Health and Retirement Longitudinal Study (CHARLS)

Cardiovasc Diabetol. 2026 Jan 20. doi: 10.1186/s12933-025-03063-2. Online ahead of print.ABSTRACTBACKGROUND: Insulin resistance and visceral adiposity are established pathophysiological drivers of cardiovascular disease (CVD). The triglyceride‒glucose (TyG) index and the Chinese visceral adiposity i

W Wenling Zheng

Insulin resistance and coronary microvascular dysfunction: a complex interplay

Cardiovasc Diabetol. 2026 Jan 20. doi: 10.1186/s12933-025-03068-x. Online ahead of print.ABSTRACTUp to 40-60% of patients undergoing coronary angiography because of angina and/or evidence of inducible ischaemia on non-invasive stress testing are diagnosed with ischaemia and non-obstructive coronary

M Martina Magistri